USP is supporting scientists, developers and manufacturers working worldwide to accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments. Trust Accelerated offers free USP technical expertise and resources to support an efficient path for regulatory predictability, while saving time and resources. Designed to fast-track bringing life-saving vaccines and treatments to market while ensuring quality development, the program builds the confidence and trust with healthcare practitioners and patients that is necessary for wide scale adoption. From discovery research and development to analytical testing, manufacturing and distribution, USP can advise on novel vaccines and treatments such as monoclonal therapies, antiviral and other small molecule therapeutics, cell therapies and immunoglobulins or convalescent plasma treatments.